SynthesisFrontiers in oncology2025

Efficacy and safety of anlotinib for the treatment of advanced bone and soft tissue sarcomas: a systematic review and meta-analysis.

Zhipeng Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.